Geneprint(r) 24 system, 400RXN kits for patient care testing.
Ended Purchase Order Awarded Last action
- Contract number
- 75N90025P00207
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $294,895
Award facts
- Opportunity
-
- GenePrint(R) 24 System, 400rxn Kits Pre-Solicitation · 25002231 · Posted Feb 10, 2025
- Contract value 100% obligated
- $294,894.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $160,360 | |
| Funding Only Action | $67,267 | |
| Original award | $67,267 |
About this award
The National Institutes of Health Clinical Center awarded a firm-fixed price Purchase Order to Promega Corporation on March 1, 2025, valued at $294,894.60 for GenePrint® 24 System, 400 reaction kits used in patient care testing. The contract is designated for sole source procurement under Federal Acquisition Regulation 13.501, as Promega is the sole manufacturer of these proprietary short tandem repeat amplification kits essential for engraftment monitoring and chimerism testing in bone marrow and stem cell transplant patients. The procurement supports the Department of Laboratory Medicine, Hematology Service at the NIH Clinical Center in Bethesda, Maryland, and carries an ultimate completion date of September 30, 2026. No small business set-aside designation was applied to this award.
Promega Corporation, a global life sciences company headquartered in Madison, Wisconsin, specializes in developing and manufacturing diagnostic and research products for federal agencies. The company holds significant standing vehicles with the NIH, including a $10 million Blanket Purchase Agreement with the NIH's Office of Logistics and Acquisition Operations and maintains relationships with multiple federal agencies including the Centers for Disease Control and Prevention, Defense Health Agency, Food and Drug Administration, and Federal Bureau of Investigation. The contracted kits fall under NAICS code 325413 for in vitro diagnostic substance manufacturing and support critical patient care operations at the NIH Clinical Center.
Quick answers
Who was awarded contract 75N90025P00207?
75N90025P00207 was awarded to Promega Corporation by NIH Clinical Center (National Institutes of Health) on March 1, 2025.
How much is contract 75N90025P00207 worth?
The government has obligated $294,895 on 75N90025P00207.
Was contract 75N90025P00207 competed?
The extent of competition for 75N90025P00207 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award